Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 812 results for "ldl"

Lydall Shares Sinking Lower, Down 2.5%

One of today's stocks on the move is Lydall (NYSE:LDL), down 2.5% to $30.78. The S&P is currently trading 0.3% lower to 2,006 and the Dow Jones Industrial Average is trading fractionally lower, 1 week ago

Shares of PMFG Rank the Highest in Terms of Sales Growth in the Industrial Machinery Industry (PMFG, GHM, CLC, LDL, NNBR)

(Comtex SmarTrend(R)) Below are the three companies in the Industrial Machinery industry with the highest sales growth. PMFG ranks highest with a sales growth of 55.7%. Graham is next with a sales growth of 45.2%. CLARCOR ranks third highest with ...
 Individual.com2 weeks ago
Business 2 Community

Avocados decrease 'bad cholesterol'

Eating an avocado a day can help decrease "bad" LDL cholesterol, according to a study by the Hass Avocado Board. Obese or overweight patients were given one of three diets: lower fat without an avocado; moderate fat with a daily avocado; or ...
 Fresh Plaza1 week ago Avocados May Help Reduce Bad LDL Cholesterol  Business 2 Community2 weeks ago An Avocado a Day Might Bring LDL Levels Down  Medscape2 weeks ago Daily avocado consumption improved LDL cholesterol  Orthopedics Today2 weeks ago


Eating 42 grams of almonds daily also significantly improved participants LDL and total cholesterol levels (07 January 2015) A new study published in the Journal of the American Heart Association found that a daily snack of 42 grams of almonds ...
 International Supermarket News2 weeks ago Almonds could reduce belly fat: study  The Hindu2 weeks ago 5 Genius Ways to Use Almonds  Time3 days ago Snacking on almonds (instead of high-carb snacks) may improve heart health  UnitedHealthcare1 week ago

Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

"In the new monthly dosing trials, ODYSSEY CHOICE I and CHOICE II, the mean percent reduction in LDL-C from baseline was consistent with that seen in previous phase 3 trials evaluating alirocumab every other week dosing," said Bill Sasiela , Ph.D., ...
 Morningstar.com2 weeks ago Scientists Claim Scrapped Roche (RHHBY) Drug Could be First Personalized Heart Med 1/21/2015  ClinicSpace4 days ago Sanofi's Phase III hypercholesterolemia trials meet primary endpoints  Individual.com1 week ago Regeneron (REGN), Sanofi (SAN.PA) Show Off Positive Cholesterol Drug Data 1/12/2015  ClinicSpace1 week ago

Shares of SPX Rank the Lowest in Terms of EPS Growth in the Industrial Machinery Industry (SPW, PLL, IEX, LDL, FLS)

(SmarTrend(R) News Watch via COMTEX News Network) -- Below are the three companies in the Industrial Machinery industry with the lowest year-over-year expected earnings per share (EPS) growth rates. The long-term growth rate is the expected annual ...
 PredictWallStreet5 days ago

FDA gives PCSK9 inhibitor priority review

The FDA granted priority review status to alirocumab, a monoclonal antibody designed to reduce low-density lipoprotein (LDL) cholesterol in statin-intolerant patients. Regeneron Pharmaceuticals and Sanofi announced the FDA's decision, which puts ...
 Cardiovascular Business15 hours ago FDA prioritizes cholesterol drug review  Reuters13 hours ago Priority Review for Hypercholesterolemia Drug Praluent  Monthly Prescribing Reference13 hours ago

PCSK9 inhibition with evolocumab (AMG 145) found to reduce LDL cholesterol

New research suggests that for patients with heterozygous familial hypercholesterolemia, treatment with evolocumab (AMG 145Amgen) every 2 weeks (140 mg) or monthly (420 mg) was well tolerated and had similar reductions in LDL cholesterol when ...
 Pharmacist.com3 days ago

Lydall Inc. (LDL) Hits New 52-week High During December 31 Session

Lydall Inc. ( LDL ) hit a new 52-week high yesterday, reaching a peak of $33.57 after opening at $33.52 and closing at $32.82 for a move of $-1.53%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading ...
 Equities.com3 weeks ago Esperion Therapeutics Inc. (ESPR) Hits New 52-week High During January 21 Session  Equities.com4 days ago Esperion Therapeutics Inc. (ESPR) Jumps 5.77% on January 16  Equities.com1 week ago Esperion Therapeutics Inc. (ESPR) Drops 12.84% on January 15  Equities.com1 week ago

Association of INSIG2 Polymorphism with Overweight and LDL in Children

by Anne-Marie Kaulfers, Ranjan Deka, Lawrence Dolan, Lisa J. Martin Background Dyslipidemia and overweight are common issues in children. Identifying genetic markers of risk could lead to targeted interventions. A polymorphism of SNP rs7566605 ...
 Plosone.org5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less